Skip to content

Public FDA record

Z-0886-06: SYNCHRON Systems Vancomycin Reagent, in vitro diagnostic. Part Number 474824.

Recall record Z-0886-06 for Beckman Coulter Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0886-06
Company in FDA record
Beckman Coulter Inc
FDA classification date
May 18, 2006
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Beckman Coulter has received reports of patient samples and quality control recovery shifting low when using Vancomycin reagent lots M507219 and M511327. Internal QC recovery was as much as 15% lower than the assigned target value.

Source facts

Action
A Product Corrective Action (PCA) letter was be sent the week of MAR 30, 2006 to all SYNCHRON Systems Vancomycin Reagent customers of lot numbers M507219 and M511327 informing them to discontinue use and discard reagent. (Letters were sent by US mail)
Initiated
2006-03-30
Root cause
Other
Terminated
2012-02-29
Distribution
Nationwide & Canada
Recall number
Z-0886-06
Recall status
Terminated
CDRH record ID
45675
FDA classified
2006-05-18
Recall event number
35258

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗